期刊文献+

甲磺酸雷沙吉兰含量测定的方法学研究 被引量:1

下载PDF
导出
摘要 目的:建立甲磺酸雷沙吉兰含量的测定方法。方法:采用高效液相谱法,用十八烷基硅烷键合硅胶为填充剂,以pH6.5的三乙氨-冰醋酸缓冲液-乙腈(52:48)为流动相;流速为1ml/min检测波长为265nm。结果:甲磺酸雷沙吉兰在19.96~399.2μg/ml范围内,与峰面积有良好的线性关系(r=0.9999),结论:本方法准确,灵敏,快捷,可用于甲磺酸雷沙吉兰含量的测定。
出处 《宜春学院学报》 2009年第2期104-105,共2页 Journal of Yichun University
  • 相关文献

参考文献2

二级参考文献7

  • 1CHEN J J,SWOPE D M.Clinical pharmacology of rasagiline:a novel,second-generation propargylamine for the treatment of Parkinson disease[J].J Clin Pharmacol,2005,45 (8):878-894.
  • 2YOUDIM M B,MARUYAMA W,NAOI M.Neuropharmacological,neuroprotective and amyloid precursor processing properties of selective MAO-B inhibitor antiparkinsonian drug,rasagiline[J].Drugs Today,2005,41 (6):369-391.
  • 3MAMDEL S,WEINREB O,AMIT T,et al.Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives[J].Brain Res Rev,2005,48(2):379-387.
  • 4THEBAULT J J,GUILLAUME M,LEVU R.Tolerability,safety,pharmacodynamics,and pharmacokinetics of rasagiline:a potent,selective,and irreversible monoamine oxidase type B inhibitor[J].Pharmacotherapy,2004,24(10):1295-1305.
  • 5Parkinson Study Group.A controlled,randomized,delayed-start study of rasagiline in early Parkinson disease[J].Arch Neurol,2004,61(4):561-566.
  • 6RASCPM O,BROOKS D J,MELAMED E,et al.Rasagiline as an adjunct to levodopa in patients with Parkinson' s disease and motor fluctuations (LARGO,Lasting effect in Adjunct therapy with Rasagiline Given Once daily,study):a randomised,double-blind,parallelgroup trial[J].Lancet,2005,365(9 463):914-916.
  • 7SODDOQIO M A,PLOSKER G L.Rasagiline[J].Drugs Aging,2005,22(1):83-91.

共引文献6

同被引文献2

  • 1刘廷辉.新型抗帕金森病药——雷沙吉兰[J].中国药学杂志,2006,41(11):877-878. 被引量:7
  • 2Fernandez M, Barcia E, Negro S. Development and validation of a reverse phase liquid chromatography method for the quantification of rasagiline mesylate in biodegradable PLGA microspheres[J]. J Pharm Biomed Anal, 2009, 49(5):1 185.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部